NEW YORK, Dec. 23, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Xerox Holdings Corporation (NASDAQ: XRX) between January 25, 2024 and October 28, 2024, both dates inclusive (the “Class Period”), of the important January 21, 2025 lead plaintiff deadline. SO WHAT: If you purchased Xerox securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arran ...

NEW YORK, Dec. 23, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Mynaric AG (NASDAQ: MYNA) between June 20, 2024 and October 7, 2024, both dates inclusive (the “Class Period”), of the important December 30, 2024 lead plaintiff deadline. SO WHAT: If you purchased Mynaric securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO ...

NEW YORK, Dec. 14, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Humacyte, Inc. (NASDAQ: HUMA) between May 10, 2024 and October 17, 2024, both dates inclusive (the “Class Period”), of the important January 17, 2025 lead plaintiff deadline. SO WHAT: If you purchased Humacyte securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT ...

NEW YORK, Dec. 12, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hasbro, Inc. (NASDAQ: HAS) between February 7, 2022 and October 25, 2023, both dates inclusive (the “Class Period”), of the important January 13, 2025 lead plaintiff deadline. SO WHAT: If you purchased Hasbro common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. W ...

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of ASP Isotopes Inc. securities during the specified Class Period, alleging misleading statements by the company regarding its technology and operational results [1][5]. Group 1: Class Action Details - The class action lawsuit is on behalf of investors who purchased ASP Isotopes securities between October 30, 2024, and November 26, 2024 [1]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested parties can join the class action by submitting a form or contacting the law firm directly [3][6]. Group 2: Allegations Against ASP Isotopes - The lawsuit claims that ASP Isotopes overstated the effectiveness of its enrichment technology and the development potential of its uranium facility [5]. - It is alleged that the company misrepresented the results of its nuclear fuels operating segment, leading to materially misleading statements about its business and prospects [5]. - The lawsuit asserts that when the true information became public, investors suffered damages [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company at the time [4]. - The firm has been consistently ranked among the top firms for securities class action settlements since 2013, recovering hundreds of millions for investors [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in handling such cases [4].

NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of ASP Isotopes Inc. (NASDAQ: ASPI) between October 30, 2024 and November 26, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 3, 2025. SO WHAT: If you purchased ASP Isotopes securities during ...

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Dentsply Sirona Inc. common stock during the specified Class Period, highlighting potential investor compensation opportunities [1][2]. Group 1: Lawsuit Details - The class action lawsuit pertains to Dentsply Sirona Inc. common stock purchases made between December 1, 2022, and November 6, 2024 [1]. - Investors who purchased Dentsply common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A lead plaintiff must file a motion with the Court by January 27, 2025, to represent other class members in the litigation [1][3]. Group 2: Allegations Against Dentsply - The lawsuit alleges that Dentsply made false and misleading statements regarding its Byte aligner solution, targeting low-income individuals without proper dental care [5]. - It is claimed that the sales strategy led to sales employees selling to patients who were contraindicated for treatment, resulting in inadequate patient onboarding processes [5]. - Reports of patient injuries related to Byte aligners were allegedly ignored by Dentsply, which failed to notify the FDA as required [5]. - The lawsuit asserts that Dentsply materially overstated the goodwill value of Byte and that positive statements about the company's business were misleading [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in handling such cases [4].

Core Viewpoint - A class action lawsuit has been filed against Celsius Holdings, Inc. for allegedly misleading investors regarding its financial performance and sales practices during the specified Class Period from February 29, 2024, to September 4, 2024 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Celsius oversold inventory to PepsiCo, leading to a significant decline in future sales and misrepresenting its financial health [5]. - Defendants allegedly made false statements about Celsius' business metrics and financial prospects, which were not as strong as indicated [5]. - Investors are encouraged to join the class action to seek compensation without upfront costs through a contingency fee arrangement [2][3]. Group 2: Legal Representation - The Rosen Law Firm, known for its success in securities class actions, is representing the investors and has a strong track record in recovering funds for clients [4]. - Investors are advised to select qualified legal counsel with a proven history in similar cases to ensure effective representation [4]. Group 3: Next Steps for Investors - Interested investors can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. - A lead plaintiff must be appointed by January 21, 2025, to represent the class in the lawsuit [1][3].

NEW YORK, Dec. 01, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024, both dates inclusive (the “Class Period”), of the important December 13, 2024 lead plaintiff deadline. SO WHAT: If you purchased Edwards securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee ar ...

NEW YORK, Dec. 01, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Warner Bros. Discovery, Inc. (NASDAQ: WBD) between February 23, 2024 and August 7, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 24, 2025. SO WHAT: If you purchased WBD securities during ...